Recursion is a technology-driven drug discovery platform that leverages AI to improve the success rate of traditional drug discovery. By analyzing cell images, Recursion's system deciphers cellular disruptions causing diseases, accelerating the development of treatments. It focuses on areas with high unmet medical needs, such as aggressive cancers and rare diseases, boasting a robust portfolio and advanced data analytics capabilities. The platform's partnerships with industry leaders and cutting-edge technologies underline its potential in AI-driven medicine development.
